Podcasts about OTC

¿Qué busca Puerto Rico en Wall Street y quién va a pagar por aumentar las pensiones?Christian Sobrino entra de pinch hitter por Luisito Herrero en este episodio de Puestos Pa'l Problema (PPP).Analizamos la visita de la gobernadora Jenniffer González a la Bolsa de Valores de Nueva York (NYSE) y qué significa para la imagen de Puerto Rico ante inversionistas, bonistas y los mercados financieros.También entramos en la discusión de #TodosSomosPensionados y las movidas políticas para aumentar las pensiones de empleados retirados del Gobierno de Puerto Rico: quién impulsa las propuestas, de dónde podría salir el dinero y cuál sería su impacto sobre las finanzas públicas y la economía.Y para completar el viaje, hablamos de Aurea Farming en Puerto Rico, porque el internet boricua nunca decepciona.

1044. Are rising healthcare costs ruining your budget? Laura answers a listener's question about how to maximize every tax advantage available for healthcare costs. You'll learn the rules for deducting them on your tax return or paying them with tax-advantaged savings accounts like HSAs and FSAs. We'll cover which expenses are tax-free and simple strategies to optimize your healthcare spending.Key Takeaways:You can only claim the medical tax deduction if you itemize deductions on Schedule A instead of claiming the standard deduction on your tax return.You can only deduct unreimbursed healthcare expenses that exceed 7.5% of your adjusted gross income (AGI), making the medical deduction best for years with high medical bills.Tax-advantaged medical savings accounts are powerful because they allow you to save 20% to 35% on qualified costs without claiming a medical deduction.Health savings account (HSA) balances roll over forever, can be invested for tax-free growth, and can be withdrawn penalty-free for non-medical expenses after age 65 (subject to ordinary income tax).Flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs) are employer-sponsored perks for cutting healthcare costs.You cannot claim an itemized medical deduction on Schedule A for any healthcare expense paid for or reimbursed using pre-tax funds from an HSA, FSA, or HRA.Lawmakers have expanded HSA, FSA, and HRA qualified expenses to cover various over-the-counter (OTC) medications and products.Discover more from Money Girl!FacebookNewsletterTranscripts available at QuickandDirtyTips.com.Email: Laura@LauraDAdams.com or leave a voicemail: (302) 364-0308. Hosted on Acast. See acast.com/privacy for more information.

Axios reported that Walmart raised its outlook while saying drug price declines pressured pharmacy results. Pharmacy margins are being squeezed by reimbursement terms set by PBMs, generic drug deflation, and the 2024 shift of pharmacy DIR fees to the point of sale. CVS Health and Walgreens Boots Alliance have cited similar headwinds, while Amazon Pharmacy, Mark Cuban Cost Plus Drug Company, and GoodRx are reshaping price transparency and consumer behavior. The Inflation Reduction Act will add Medicare drug price negotiations in 2026 and a $2,000 Part D out-of-pocket cap in 2025, which could shift volumes and reimbursement flows. Rising demand for GLP-1 drugs adds inventory and authorization complexity without guaranteed margin lift. Walmart's 2024 exit from its health clinics highlights how reimbursement pressures influence strategy, pushing focus back to core pharmacy services and OTC products.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

Epiduo is now available over the counter — and in this full episode of the Science of Skin Podcast, board-certified dermatologists Dr. Ted Lain and Dr. Patti Farris break down everything you need to know about this fixed-dose combination acne treatment.From the landmark phase 3 clinical trial data to real-world tolerability, scarring reduction, and the risks of compounded alternatives, this is the definitive deep dive on adapalene 0.1% and benzoyl peroxide 2.5%.In this episode:✅ Why Epiduo's move to OTC is a game-changer for acne patients facing prescription barriers✅ Full breakdown of the 2009 phase 3 trial: 1,600+ patients, 60 study centers, 4 treatment cohorts✅ 67% reduction in inflammatory lesions and 60% reduction in total lesion count by week 12✅ IGA success rates — 35% achieved clear/almost clear skin vs. 22-24% with monotherapy alone✅ Phase 3B international trial data across diverse Fitzpatrick skin types✅ Excellent tolerability data — erythema, dryness, and irritation all rated below "mild"✅ How Epiduo addresses the full acne lesion life cycle, including scarring and PIH✅ Why formulation science and FDA-approved testing matter vs. compounded alternatives✅ The CeraVe/Cetaphil CAMP regimen (cleanse, moisturize, protect) for acne patients✅ Real-world pricing, dosing, and application tips for OTC EpiduoThis episode of the Science of Skin Podcast is sponsored by Galderma.Have a question or an idea for a future episode? Email inquiry@scienceofskinsummit.com.Join us at the Science of Skin Summit, September 17-20 in Austin, TX, or the new Science of Skin Longevity Conference in Scottsdale, February 2027. Learn more at scienceofskinsummit.com.If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment.

In this episode of the Rundown Brendan, Hunter, & Tevo focus heavily on Ethereum's recent strength, Bank of America's exposure to Bitmine, rising RWA activity on Ethereum, Paul Tudor Jones adding back Bitcoin exposure, and Stanley Druckenmiller's family office getting exposure to Hyperliquid through an equity wrapper. They also cover the Genius Act, Clarity Act pressure, SEC crypto rulemaking, Citi's constructive regulatory comments, and Nasdaq moving toward 24-hour stock trading as traditional finance slowly starts to look more like crypto.Check out Omaha Steaks and use my code BEEF for a great deal: https://www.omahasteaks.comCheck out Scribe and use my code scribe.how/CRYPTO101 for a great deal: https://scribe.comCheck out Quince: https://quince.com/CRYPTO101Check out Shopify: https://shopify.com/crypto101Check out ShipStation and use my code crypto for a great deal: https://www.shipstation.comGet my #1 altcoin pick for this month.Get immediate access to my entire crypto portfolio for just $1.00 today! Get your FREE copy of "Crypto Revolution" and start making big profits from buying, selling,Get immediate access to my entire crypto portfolio.. just $1.00 today! Go here to get access: https://www.crypto101insider.com/cryptnation-directm6pypcy1?utm_source=Internal&utm_medium=YouTube&utm_content=Podcast&utm_term=20250916Get your FREE copy of "Crypto Revolution: Your Guide To The Future of Money". In this book, I reveal how to make (and keep) a fortune during this crypto bull run! http://www.cryptorevolution.com/free?utm_source=Internal&utm_medium=YouTube&utm_content=Podcast&utm_term=20250916Chapters00:00 -Intro 00:37 - From MSCI and Bloomberg to Derivnex03:15 - Why crypto and tokenization matter now04:45 - Perpetual futures and tokenized index exposure06:15 - Atomic settlement and capital velocity explained07:25 - Why perpetual futures threaten traditional exchanges10:45 - OTC swaps, ISDAs, KYC, and institutional counterparties13:45 - Why Derivnex chose Canton16:35 - Stablecoins, tokenized deposits, and digital asset migration18:10 - Institutional adoption and green lights for tokenized financeSubscribe to YouTube for Exclusive Content:https://www.youtube.com/@crypto101podcast?sub_confirmation=1Follow us on social media for leading-edge crypto updates and trade alerts:https://twitter.com/Crypto101Podhttps://instagram.com/crypto_101*This is NOT financial, tax, or legal advice*Boardwalk Flock LLC. All Rights Reserved  ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Fog by DIZARO https://soundcloud.com/dizarofrCreative Commons — Attribution-NoDerivs 3.0 Unported — CC BY-ND 3.0 Free Download / Stream: http://bit.ly/Fog-DIZAROMusic promoted by Audio Library https://youtu.be/lAfbjt_rmE8▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Our Sponsors:* Check out Omaha Steaks and use my code BEEF for a great deal: https://www.omahasteaks.com* Check out Quince and use my code quince.com/CRYPTO101 for a great deal: https://www.quince.com* Check out Scribe and use my code scribe.how/CRYPTO101 for a great deal: https://scribe.com* Check out ShipStation and use my code crypto for a great deal: https://www.shipstation.com* Check out Shopify and use my code shopify.com/crypto101 for a great deal: https://www.shopify.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Today, I'm joined by Chris Kiple, CEO of Solius Labs.   A decade in development, Solius's FDA-cleared UVB light therapy device personalizes dosage by skin type, aiming to replicate the benefits of sunlight while minimizing carcinogenic risk.    In this episode, we discuss sunlight as a foundational pillar of health and longevity.    We also cover: Why sun avoidance is deadlier than smoking Designing a skin scanner for personalized UVB dosing Moving UVB therapy from clinical dermatology to consumer health Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    Website: www.solius.com  Instagram: https://www.instagram.com/soliuslabs    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com  to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (00:29) Swedish longevity study (01:20) Chris background and Solius overview (02:05) UVB light therapy foundation (04:00) 10-year development and timing (05:07) Sun exposure evolution and skin type (08:10) Solius technology and personalized dosing (09:35) Skin scanning and dosing mechanism (11:00) FDA clearance and safety focus (12:40) OTC vs. prescription positioning (14:15) Safety risk contextualization (15:42) Healthcare partnerships strategy (17:50) Dermatology focus (19:00) Orthopedic and cardiovascular applications (20:32) Longevity clinic partnerships (22:35) Swedish and UK biobank studies (26:00) Hormone production benefits (27:20) Cardiovascular and nitric oxide improvements (28:30) Microbiome diversity impact (31:15) Platform evolution and future devices (33:20) Team-building and advisory board (34:45) Listening to early users (36:40) Where to find (38:07) Conclusion

In this episode of the Crypto 101 Podcast, George Harrington, CEO of Derivnex, joins from the Out East Summit to explain how DRW is building infrastructure to bring OTC derivatives on chain. He breaks down how Derivnex is focused on moving traditional swap transactions, index total return swaps, digital settlement, tokenized assets, stablecoins, and tokenized deposits into a more efficient blockchain-based workflow.Check out Omaha Steaks and use my code BEEF for a great deal: https://www.omahasteaks.comCheck out Scribe and use my code scribe.how/CRYPTO101 for a great deal: https://scribe.comCheck out Quince: https://quince.com/CRYPTO101Check out Shopify: https://shopify.com/crypto101Check out ShipStation and use my code crypto for a great deal: https://www.shipstation.comGet my #1 altcoin pick for this month.Get immediate access to my entire crypto portfolio for just $1.00 today! Get your FREE copy of "Crypto Revolution" and start making big profits from buying, selling,Get immediate access to my entire crypto portfolio.. just $1.00 today! Go here to get access: https://www.crypto101insider.com/cryptnation-directm6pypcy1?utm_source=Internal&utm_medium=YouTube&utm_content=Podcast&utm_term=20250916Get your FREE copy of "Crypto Revolution: Your Guide To The Future of Money". In this book, I reveal how to make (and keep) a fortune during this crypto bull run! http://www.cryptorevolution.com/free?utm_source=Internal&utm_medium=YouTube&utm_content=Podcast&utm_term=20250916Chapters00:00 -Intro 00:37 - From MSCI and Bloomberg to Derivnex03:15 - Why crypto and tokenization matter now04:45 - Perpetual futures and tokenized index exposure06:15 - Atomic settlement and capital velocity explained07:25 - Why perpetual futures threaten traditional exchanges10:45 - OTC swaps, ISDAs, KYC, and institutional counterparties13:45 - Why Derivnex chose Canton16:35 - Stablecoins, tokenized deposits, and digital asset migration18:10 - Institutional adoption and green lights for tokenized financeSubscribe to YouTube for Exclusive Content:https://www.youtube.com/@crypto101podcast?sub_confirmation=1Follow us on social media for leading-edge crypto updates and trade alerts:https://twitter.com/Crypto101Podhttps://instagram.com/crypto_101*This is NOT financial, tax, or legal advice*Boardwalk Flock LLC. All Rights Reserved  ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Fog by DIZARO https://soundcloud.com/dizarofrCreative Commons — Attribution-NoDerivs 3.0 Unported — CC BY-ND 3.0 Free Download / Stream: http://bit.ly/Fog-DIZAROMusic promoted by Audio Library https://youtu.be/lAfbjt_rmE8▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Our Sponsors:* Check out Omaha Steaks and use my code BEEF for a great deal: https://www.omahasteaks.com* Check out Quince and use my code quince.com/CRYPTO101 for a great deal: https://www.quince.com* Check out Scribe and use my code scribe.how/CRYPTO101 for a great deal: https://scribe.com* Check out ShipStation and use my code crypto for a great deal: https://www.shipstation.com* Check out Shopify and use my code shopify.com/crypto101 for a great deal: https://www.shopify.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Stephen Grootes speaks to Andre Cilliers, Currency Risk Specialist and Director at TreasuryONE, about South Africa’s plans to introduce mandatory central clearing for certain OTC derivatives by 2028, what this means for transparency and counterparty risk, and how the new rules could change the way businesses manage currency and interest-rate exposure. The Money Show is a podcast hosted by well-known journalist and radio presenter Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape. Thank you for listening to a podcast from The Money Show. Listen live on Primedia+ weekdays from 18:00 to 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa Follow us on social media 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Organizations demand infinite growth in finite markets. Leaders are left at the crossroads of irreconcilable missions, balancing economic imperatives with the well-being of their teams. What happens when the equation simply has no solution? The cost of execution is sometimes your own breaking point.Welcome to Pharma Minds, Summer Series "Executing differently takes courage". For this final episode of our miniseries, I wanted to explore what execution reveals about oneself at the deepest level. I chose to speak with Patrice because his journey shows what it concretely costs to actually do what you said you would do. Execution eventually ceases to be a professional requirement. It becomes a personal decision to put skin in the game, without a safety net, but with singular intention. Patrice Zagame is the Founder and CEO of Eolias Health, an OTC lab for plant-based products aimed at the Brazilian market. After spending 35 years in the pharmaceutical industry and managing global subsidiaries for 16 years, he knows the weight of impossible contexts. From handling severe price cuts and sales force reductions in France to surviving executive burnout and ultimately funding his own venture, Patrice embodies the courage of leaving the comfort of a massive organization to truly walk the talk.In this episode, we cover:◾️The Impossible Equation : Balancing double-digit growth demands with saturated markets and massive price cuts.◾️Choice Versus Chance : Why letting an organization dictate your pace can cost you the most crucial turns in your career.◾️The Silent Break : Recognizing the boiling point of executive burnout and walking away to change the equation.◾️Managing the Smartest Room : Stepping back from ego to lead experts who know more than you do.◾️Walking the Talk : Leaving corporate security to fund an entrepreneurial venture from scratch.Commitment is not a corporate posture. It is a daily decision renewed in the face of impossible contexts. At some point, managing the system is no longer enough. 

We continue our Summer Playlist this week by welcoming Sunil Kashyap back into the SmarterMarkets™ studio. Sunil is Managing Director at FinMet Pte Ltd., Singapore.   David Greely sits down with Sunil to discuss the surge of new developments and new initiatives being announced in Asia's gold and silver markets including the growth in trading activity of Abaxx Exchange's gold and silver futures markets in Singapore, the Hong Kong Exchange reviving its gold futures market in Hong Kong, and Singapore pursuing an OTC gold clearing initiative to create a Loco Singapore market.  

The CPG Guys are joined in this episode by Philip Durocher, CMO of Opella, maker of iconic OTC health products include Xyzol, Allegra, Dulcolax & IcyHot and Kristen DiCorleto Head of Marketing for CVS Media Exchange (CMX) the Retail Media Division of CVS Health.This episode was recorded in Cannes France at the 2026 Cannes Lions International Festival of Creativity.This episode is sponsored by CMX.Follow Philip on LinkedIn at: https://www.linkedin.com/in/philip-durocher/Follow Opella online at: http://opella.comFollow Kristen on LinkedIn at: https://www.linkedin.com/in/kristen-dicorleto/Follow CMX online at: https://www.cvsmediaexchange.com/CPG Guys Website: http://CPGguys.comFMCG Guys Website: http://FMCGguys.comSheCOMMERCE Website: https://shecommercepodcast.com/Rhea Raj's Website: http://rhearaj.comLara Raj in Katseye: https://www.katseye.world/DISCLAIMER: The content in this podcast episode is provided for general informational purposes only. By listening to our episode, you understand that no information contained in this episode should be construed as advice from CPGGUYS, LLC or the individual author, hosts, or guests, nor is it intended to be a substitute for research on any subject matter. Reference to any specific product or entity does not constitute an endorsement or recommendation by CPGGUYS, LLC. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.CPGGUYS LLC expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential or other damages arising out of any individual's use of, reference to, or inability to use this podcast or the information we presented in this podcast.

Low Value Mail is a live call-in show discussing current events, politics, conspiracies and much more.Every Monday night at 7pm ETSupport The Show:

El Tríbolico es único.Salen los relatos del hombre más interésate del mundo. Mío cuenta algunas las historias de su jefe, “El Tribólico” y sus hazañas adentro de un avión.Primero fue Venezuela y ahora le tocó el turno a Colombia. Dicho país latinoamericano es sacudido por un terremoto de 7.4 hasta el punto de ser declarado por su gobierno como un desastre total. Lo que hace que varios países se unan a los esfuerzos para los afectados. Puerto Rico se une al esfuerzo, pero esto no pasa de desapercibidos a los puertorriqueños ya que cuestionan este acto cuando su gobernadora tiene a la Isla en crisis total.La crisis del agua continúa en Puerto Rico con los embalses y suministros. El efecto del Niño ha empeorado la situación y la ineficiencia del la Autoridad de Acueductos y Alcantarillados no alivia la situación. ¿Hasta cuándo los puertorriqueños seguirán aguantando semejante abuso?Radioactive Girl y Voodoo Ranger regresan al Manicomio y exploran las nuevas portadas de varían clásicos del podcast. Se suscita una situación bien poco usual en un vuelo de Frontier Airlines a Puerto Rico mientras el OTC les tiene un mensaje a los Güanimes. En especial a Super Servo.La WNBA sigue dando de qué hablar cuando sus jugadoras quieren igualdad en comparación con la NBA. Pero con toros los incidentes que han ocurrido con sus jugadoras…¿realmente lo lograrán?And holly shit! Norma Burgos is back!Con las participaciones deGustavo “El Carnepuerco” Cáez Carlos “Voodoo Ranger” Solá Deborah “Radioactive Girl” MateoMío: El Huevo FelizSharon “La Rubia de América” Solá Giancarlo “La Maldad” MartínezAlberto “Súper Servo” ReyesAhora puedes conseguir la mercancía oficial de SE RASCÓ ASÍ. ¡Visita nuestro “Güanime Store” y chequea lo nuevo que tenemos!https://guanime-store.printify.me/category/all/1¡Chequea nuestro Linktree!https://linktr.ee/serascoasi?utm_source=linktree_profile_shareADVERTENCIA: El material discutido en este podcast no es apto para menores de 18 años y no representa la opinión de Spotify. Sugerimos discreción.) ©2026 Se Rascó Así Productions. Derechos Reservados.

In today' episode Nando T and Jadaveon the Pebbles Johnson cover Summerslams aftermath and what they feel is next for the WWE superstars. We get wild with ideas in this episode and we discuss our top 5 matches/takeaways from Summerslam. Table of topics, you just made the list, smackdown, RAW and so much more!!! CHEERS!!!JERKING THE CURTAINROUND TABLE OF TOPICSNEWSThe Rock has taken a wrestler under his wing……who is it?One Bella in, one Bella outBrock Lesnar announces he is retired Rey Mysterio announces tournament, winner gets Roman for a title shot “You Just Made the List” Give me your top 5 matches from Summerslam SMACKDOWNFinn Balor kicks off the show and Sami wants attention but so does Gunther and Nick answers The baddies get the win over the Barbie's…..Charlotte vs Jade looking good Tala Tonga talks…..the Sons of Haku has a nice ring for a tag name Tag teams continue to suck no changes Does Trick vs Punk move the needle???Baron calls his shot on Trick Fenix vs JD was great for business Lash makes quick work of Giulia, should we add Giulia to the list???Punk patting Cody on the head is lowkey funny, Cody in all black is looking really good right now  SummerSlamIyo and Liv put on a great match, Liv walks away with the winSolo Dolo steals the match and LA Knight gets the dub! YEAH!!!Nick Aldis looking like a Greek God, dude is built!!! What a great match between him and Gunther……Gunther gets the win but Aldis wins the fans Wow Jacy Jayne coming out like HBK, another great match!!! WWE is listening as the Bellas turn on Paige…….time for that Paige run Cody coming out like Guile is great for business, these guys put on a good'ol fashion wrestling match!!! Possibly the best match of the night. Confused with the Orton interference??? Brock and Oba were off to a great start but the ending left me empty Triple H reinstating Aldis is great for business.  SummerSlam Night 2Nick Aldis kicks off Night 2 with a very nice surprise KEVIN OWENS, Sami's look is priceless.  Did not see Corbin getting the dub……what's next?Let's fucking goooooooooooooo CHELSEA GREEN!!! Great match from the females, Lash Legends looked great for business!!!The human monies on a pole match didn't disappoint!!! DanHausen gets the monies Chad Gable and Penta put on a great wrestling match!!! Chad deserves gold, great opportunity for him We literally just witnessed EPIC history in the making!!! Seth and Roman just became a top 5 match in WWE history…….12 years in the making and they did not skip a beat!!! I cant say enough how this match moved me. I just wish I could have been there live!!! True WWE magic RAWThe OTC kicks off the show and lets everyone know he kept his promise. LA Knight resets Roman back to factory settings….great exchange Evans beats All Ego but gets a 7ft tall boot to the face, Big Cass is back and still no sign of EnzoOrders from the OTC on LA Knight is grrrrreat for business Liv Morgan is nails on a chalkboard, thoughts on the IC titles new look???DQ for Sol and Perez, Becky cooked Liv I don't even know how she will come backLa Primera returns and gets some holy shit chants Oba takes the torch and it shines bright, Bron looks like he has a problem Joe Hendry is another TNA star struggling in a big pool of WWE talent Big Cass is here to stack bodies, great job from the cameraman showing his height Penta and Chad get a dub over Dirty Dom and the Funko Pop Does Heyman have a Brekker problem???Fatu vs Keys was intense, great match Check out the Smackdown Siblings on TikTok @ariannaandthomasEpisodes dropping weekly!!!Follow us on TikTok @the.funkaholiks.pod THEE POD THAT TALKS WHAT THEY LOVE 

In this episode of CoROM Conversations, Aebhric O'Kelly is joined by Dr Bill Vasios to discuss one of the most overlooked aspects of remote and austere medicine: the intelligent use of over-the-counter (OTC) medications in austere primary care.Rather than focusing on advanced equipment and prescription drugs, this discussion explores how a carefully selected collection of inexpensive, widely available medications can effectively manage many of the illnesses and injuries encountered in remote, expeditionary, humanitarian and disaster settings.The conversation emphasises clinical reasoning, careful assessment, conservative prescribing, and making the most of simple interventions before escalating treatment.Chapters00:00 – Introduction: Why OTC medicines matter in austere medicine02:22 – Traveller's diarrhoeaAssessmentOral rehydrationLoperamide: when to use it (and when not to)06:54 – Upper respiratory infectionsSymptom managementSalt-water garglesSaline spraysWhen antibiotics are unnecessary13:34 – Musculoskeletal injuriesPain packsDiclofenacPatient-guided pain managementRICE and the ice debate20:45 – Allergic rashes and contact dermatitisHydrocortisoneAntihistaminesOatmealRecognising anaphylaxis23:02 – Insect bites and stingsLocal treatmentCold therapyWhen to escalate care25:21 – DehydrationOral rehydrationIV versus oral fluidsHydration strategies in the field29:59 – Heat illnessCooling methodsField managementPreventing heat injury32:15 – Acid reflux in austere environmentsAntacidsGingerPractical management tips32:15 – Minor wound careIrrigationSoap versus antisepticsDakin's solutionAlcohol and iodinePractical wound cleaning36:45 – Building the ideal austere OTC medical kitEssential medicationsDressingsTapeWater purificationSplintsEpiPensMulti-use equipment41:20 – Final discussion, audience questions and wrap-upThe discussion concludes by assembling a practical remote medicine kit, including:Oral Rehydration Salts (ORS)ParacetamolIbuprofenLoperamideAntacidsOral antihistaminesHydrocortisone creamAntifungal creamTopical diclofenacZinc oxide tapeCohesive bandage (Coban/Vet Wrap)SalineSoapCling filmDressingsGauzeSunscreenWater purification equipmentSAM splintsEpiPenCompact medication organiser (FOLCA)Key Take-Home MessagesGood assessment should always precede medication.Oral hydration remains the cornerstone of treating dehydration.Many common conditions can be managed safely with inexpensive OTC medications.Every item carried should ideally have multiple uses.Patient education and involvement improve outcomes.Simple treatments, applied correctly, are often more effective than complicated ones.Featured SpeakersAebhric O'Kelly: Paramedic, educator and Rector of the College of Remote and Offshore Medicine.Dr Bill Vasios: Physician Associate, educator and specialist in austere and remote healthcare.Resources MentionedWorld Health Organization Oral Rehydration Solution (ORS)Wilderness Medical Society clinical practice guidelinesJoint Trauma System Clinical Practice Guidelines (JTS CPGs)Bristol Stool ChartOttawa Ankle RulesListen, Learn, DeployWhether you're preparing for an expedition, humanitarian mission, offshore deployment or remote clinic, this episode provides practical, evidence-informed advice on building a lightweight, effective medical kit capable of managing the conditions you are most likely to encounter.

El ceviche viene grande y chiquito. ¿Cuál quieres?El programa comienza con varios problemas técnicos los cuales llevan a Marcos a explicar cómo uno puede dividir en StreamYard los diferentes estudios como lo son “Cinemateria”, “Hartos de Odio” y “El Manicomio Inhabitable”.La Maldad nos habla sobre los raros cambios que se están realizando en el Departamento de Educación. Desde la posibilidad de “interlocking” hasta clases remoto y aires acondicionados en pueblos en donde la electricidad es casi inexistente.La WNBA sigue dando de qué hablar cuando una de sus jugadoras da su honesta opinión en contra de los “trans” compitan en deportes exclusivos para mujeres biológicas. Lo que ha desatado una ola de protestas no tan solo por el público, sino por personas adentro de la organización. Las cosas están malas y Gustavo quiere someterse a un emprendedor negocio. La venta del ceviche. Y te lo ofrece en dos tamaños. El ceviche grande o….¿¿cevichito??La nueva película de Spiderman ha traído eventos para recordar en los cines. Desde una “catimba” a una persona por dar “spoilers” durante su presentación hasta flatulencias de tal magnitud que tuvieron que desalojar el lugar. Pero mientras eso ocurre, luego de décadas de servicio, la escuela superior Manuel A. Toro de Caguas decide cambiar sus uniformes hasta parecer al punto quienes asisten a la escuela son empleados de Pep Boys.Discutimos brevemente a invasión de ciudadanos de Marruecos hacia Ceuta, España. Lo que provocó la situación y como los españoles resolvieron el asunto. Y no necesariamente no fue gracias a su presidente.Y Súper Servo cae en el dedo del “OTC”. Say what?!?!?Con las participaciones deGustavo “El Carnepuerco” Cáez Gustavito “OTC” CáezAlberto “Super Servo” ReyesProf. Marcos Rodríguez Giancarlo “La Maldad” Martínez Sharon “La Rubia de América” Solá Ahora puedes conseguir la mercancía oficial de SE RASCÓ ASÍ. ¡Visita nuestro “Güanime Store” y chequea lo nuevo que tenemos!https://guanime-store.printify.me/category/all/1¡Chequea nuestro Linktree!https://linktr.ee/serascoasi?utm_source=linktree_profile_share(ADVERTENCIA: El material discutido en este podcast no es apto para menores de 18 años y no representa la opinión de Spotify. Sugerimos discreción.) ©2026 Se Rascó Así Productions. Derechos Reservados.

Would you trust Bitcoin and a Lightning Network digital wallet to rebuild your life in El Salvador after COVID destroyed your business and the banks turned away? Kevin Ayala (@KevinAyala24) did, and that choice runs through his whole story. He grew up training as a violinist in El Salvador's national orchestra, and he first heard about Bitcoin in 2009 from a high school teacher. He didn't have a credit card or access to an exchange, so he walked away from it more than once over the next decade, a reminder of how much friction used to stand between a person and true self-custody.Then COVID hit. Kevin had just opened a computer and phone repair shop backed by a $30,000 family bank loan, and the lockdown shut it down within three months. He talks openly about carrying that debt with no income coming in, and about his parents refusing to make him feel guilty for it. The traditional financial system had given him a loan, but no way to keep earning against it once the doors closed.Bitcoin is what got him back on his feet, and it happened outside the banking system entirely. Kevin started earning small amounts through freelance design and repair work, paid directly over the Lightning Network. He found the Bitcoin Beach Wallet, ran his own Lightning node, and built a habit of stacking sats one gig at a time in El Zonte, the town where this circular economy took root before most of the world had heard of it. A digital wallet with no bank attached became his entire income, and a crash course in financial literacy along the way.From there, Kevin gets into teaching at the House of Bitcoin, co-founding Asobitcoin, and joining 40 Acres, an OTC desk for businesses named after a broken 19th century government promise. The 40 acres and a mule were taken back from the people who earned them. Bitcoin can't be taken back the same way. He talks about financial literacy spreading through El Zonte neighbor to neighbor, and how that kind of grassroots community building is the actual mechanism behind a working circular Bitcoin economy.The episode closes with Kevin's current role as CEO of Blink Wallet for El Salvador, and this is where it gets uncomfortable for anyone who assumes legal tender status solved everything. He explains why Blink got debanked, what Stablesats actually is under the hood, and why regulators keep confusing sound tech innovation built on Bitcoin with the kind of risk they're used to policing. Kevin's stacking, building, and helping the next person do the same in a country where the banks still haven't caught up to the law. Subscribe, share this with someone who thinks they missed their window, and tell us in the comments, would you have trusted your parents' credit card with $10 of Bitcoin back in 2011?—Bitcoin Beach TeamLearn more about Kevin Ayala:X: https://x.com/KevinAyala24X: https://x.com/40acres_svX: https://x.com/blinkbtcWeb: https://www.40acres.pro/Web: https://www.blink.sv/Support and follow Bitcoin Beach:X: https://www.twitter.com/BitcoinBeach IG: https://www.instagram.com/bitcoinbeach_sv TikTok: https://www.tiktok.com/@livefrombitcoinbeach Web: https://www.bitcoinbeach.com STAY AT BITCOIN BEACH:  https://www.stayatbitcoinbeach.com/punta-mango-villasBrowse through this quick guide to learn more about the episode:00:00 Intro01:38 Why couldn't people buy Bitcoin in 2009 without exchanges or credit cards?05:18 Can you make a living as a musician in El Salvador?07:25 How did COVID lockdowns destroy small businesses in El Salvador?10:20 How to earn Bitcoin online through freelance work instead of buying it?13:31 What is the Bitcoin Beach Wallet and how did it become Blink?19:07 What is the House of Bitcoin and how does Asobitcoin support Bitcoin in El Salvador?27:13 How do Bitcoiners network and find jobs in the Bitcoin industry?32:41 What does 40 acres and a mule have to do with Bitcoin self-custody?39:21 Why do banks close accounts of Bitcoin companies in El Salvador? Live From Bitcoin Beach

WWE Monday Night Raw is live in Inglewood, California on July 27, 2026!Join the Ant's as they cover WWE Monday Night Raw! The Hell in a Cell is lowered as Brock Lesnar locks Oba Femi inside the cell to play mindgames. WWE World Tag Team Champions The Vision battle Alpha Academy in a non-title match. Afterwards, The Vision destroys Otis. Rusev challenges Je'Von Evans. Joe Hendry and Danhousen perform a concert until Ricky Garcia, Dominik Mysterio, and JD McDonagh attack both men, leading Danhousen to make his match against Dominik at WWE SummerSlam a Human Monies on a Pole Match., Ethan Page battles Rey Mysterio. Jacob Fatu & The Usos brawl with Solo Sikoa, Royce Keys, and LA Knight ahead of their match. We see a new WWE Women's Intercontinental Champion crowned as Raquel Rodriguez defeats the Champion Sol Ruca. WWE World Champion Roman Reigns comes face to face with Seth Rollins, which leads to the OTC taking out Rollins with a spear, however, The Architect is able to land a Stomp to Roman onto a steel chair. 

From brittle nails to fungal infections to gel manicure myths—your nails reveal more about your health than you might think.In this episode, Dr. Sandy Skotnicki and Marlo Sutton break down the science of nails, common concerns, and what actually works in nail care.Listeners will learn:What nails are made of and how they grow (and why toenails take so much longer!)The real cause of brittle nails—and why water exposure is often the culpritThe truth about white spots (hint: it's not calcium deficiency)How to recognize and treat fungal nail infections—and why OTC treatments often fall shortThe rise in acrylate allergies from gel and acrylic nailsWhether UV nail lamps are actually dangerousWhat causes painful swelling around nails (paronychia), and how to treat itThe psychology behind nail picking (onychotillomania)What to look for with nail melanomaPlus, practical, dermatologist-approved tips to keep your nails healthy—without overcomplicating your routine.Every Thursday on Skin to It, dermatologist Dr. Sandy Skotnicki and beauty enthusiast Marlo Sutton guide you through the maze of skincare, cutting through the noise to help you achieve your healthiest skin. Subscribe to ensure you never miss out on our skincare wisdom!Love our podcast? Tell us what you love about the show to help others discover it too, by sharing your review.Skin to It is a skincare podcast brought to you by Bioderma.For more information about Skin to It, visit skintoitpodcast.com.Follow us on social media at Dr. Sandy Skotnicki and Marlo Sutton.

Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTKendall Guthrie, PharmD, BCACPDirector of Co-Curriculum/Clinical Professor,UMKC School of Pharmacy Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer.2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.Rachel Maynard and Kendall Guthrie have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-289-H01-PInitial release date: 7/27/2026Expiration date: 7/27/2029Additional CPE details can be found here.

Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTKendall Guthrie, PharmD, BCACPDirector of Co-Curriculum/Clinical Professor,UMKC School of PharmacyGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer.2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-289-H01-P Initial release date: 7/27/2026Expiration date: 7/27/2029Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Can one of the world's greatest long-term investors teach options traders a thing or two? To celebrate the 400th episode of Options Boot Camp, Mark Longo welcomes Dan Passarelli and special guest Russell Rhoads for a fascinating deep dive into Warren Buffett's real options strategies. While Buffett famously called derivatives "financial weapons of mass destruction," the reality is far more nuanced. The panel explores how Berkshire Hathaway has used cash-secured puts, covered calls, long-dated index options, warrants, and over-the-counter derivatives to build positions, generate income, and manage risk. The discussion also covers Buffett's famous global index put trades, why he prefers selling puts to enter positions, how he thinks about valuation, risk management, and knowing when to admit mistakes. Whether you're a buy-and-hold investor or an active options trader, this milestone episode offers timeless lessons on patience, discipline, and using options as investing tools rather than speculation. In this episode: Celebrating 400 episodes of Options Boot Camp The truth behind Buffett's "financial weapons of mass destruction" quote Why Buffett sells cash-secured puts Covered calls and long-term investing Buffett's legendary global index put trades OTC derivatives vs. listed options Risk management lessons every options trader can use Buffett's biggest investing mistakes—and what they teach us

Interest rate swaps are the largest derivatives market in the world—but they're also one of the least understood. In this episode, host Mark Longo is joined by Chris Dopp and Milena Dimitrova from Eurex for an in-depth look at OTC interest rate swaps, central clearing, and why this market sits at the heart of the global financial system. Topics include: What interest rate swaps are and why institutions rely on them Why the OTC swaps market exceeds $500 trillion in notional outstanding How central clearing transformed the market after the financial crisis Counterparty risk, clearing houses, and capital efficiency Dodd-Frank, EMIR, MiFID, and the evolving regulatory landscape Why futures, options, and swaps are increasingly interconnected The future of OTC clearing, tokenization, and even... swaptions

Can one of the world's greatest long-term investors teach options traders a thing or two? To celebrate the 400th episode of Options Boot Camp, Mark Longo welcomes Dan Passarelli and special guest Russell Rhoads for a fascinating deep dive into Warren Buffett's real options strategies. While Buffett famously called derivatives "financial weapons of mass destruction," the reality is far more nuanced. The panel explores how Berkshire Hathaway has used cash-secured puts, covered calls, long-dated index options, warrants, and over-the-counter derivatives to build positions, generate income, and manage risk. The discussion also covers Buffett's famous global index put trades, why he prefers selling puts to enter positions, how he thinks about valuation, risk management, and knowing when to admit mistakes. Whether you're a buy-and-hold investor or an active options trader, this milestone episode offers timeless lessons on patience, discipline, and using options as investing tools rather than speculation. In this episode: Celebrating 400 episodes of Options Boot Camp The truth behind Buffett's "financial weapons of mass destruction" quote Why Buffett sells cash-secured puts Covered calls and long-term investing Buffett's legendary global index put trades OTC derivatives vs. listed options Risk management lessons every options trader can use Buffett's biggest investing mistakes—and what they teach us

Anhören, lachen, abstimmen! Von 1LIVE.

In today's episode the gang is back!!! Nando T and the OTC are loving wrestling, Arianna brings some fantastic storylines to the table during You Just Made the List!!! We get into current news, smackdown, RAW and AEW!!! CHEERS!!!JERKING THE CURTAINROUND TABLE OF TOPICSNEWSKeith Lee expected to be done with wrestling, Michin announces divorce Wyatt's returning to WWE???“You Just Made the List” Give me a storyline for Baron Corbin SMACKDOWNNick Aldis is back and introduces his new Champ Cody and Punk for SummerSlam!!! Let's goooo, can't wait for those promos Finn vs Tala Tonga gets me excited Truth protecting Keyes is interesting Fatu vs Solo at SummerSlam…..book it The Bloodline family is dysfunctional at best, is Jimmy dropping hints for a Naomi return???Johnny Wrestling is the voice of the voiceless This Charlotte vs Jade is cooking……hopefully Alexa Bliss gets back TWISTED Baron Corbin!?! Very interested in seeing how he mixes with Trick Williams…..great to see End of Days Gunther snaps…..Aldis and Gunther is happening RAWBrock continues the head games with Oba, the hype is real Iyo NEEDS to beat Liv at Summerslam!!! Otis my guy, why lower yourself to Maxxine??? You had Mandy Rose for crying out loud I hate to say it but the Vision got one over on this crowd…..that was some heat Jacob aging fast in the Bloodline, looking like an elder Let's goooo Solo and LA Knight working together……YEAHHHHREALLY!?! Maxxine replacing Heyman Who was AP talking to???The Shield vignettes are nostalgic and the perfect recipe for Seth vs Roman What the fudge happened to Lyra!?! Lawwwd have Mercy…..what a great exchange Big Cass returns 8/3, where's Enzo???Wow Joe Hendry!!!Gable vs Penta moves the needle 14 YEARS!!! Round 1 goes to Roman in the verbal judo…..this is so fucking good right now!!! Drinking all them pitchers of kool aid TNA10 count with Always Ready AriannaCheck out the Smackdown Siblings on TikTok @ariannaandthomasFollow us on TikTok @the.funkaholiks.podEpisodes dropping weekly!!! THEE POD THAT TALKS WHAT THEY LOVE 

*Are over-the-counter (OTC) peptides legal? How are they regulated, and what do independent pharmacy owners need to know before offering them? I'mDr. Lisa Faast and I'm breaking down the differences between peptides as dietary supplements and FDA-approved drugs. I'll explain the regulatory framework, proper labelling requirements, approved routes of administration, and why she believes OTC peptides represent one of the biggest opportunities for independent pharmacies. If you're a pharmacy owner trying to figure out how to legally and profitably get into the peptide space without compounding or dispensing headaches, this one's for you.**   **Show Notes:** 1. **Introduction** [0:00] 2. **Understanding Peptides and Their Regulatory Framework ** [0:14] 3. **Regulatory Guidelines for OTC Peptides** [2:24] 4. **Practical Examples and Labeling Requirements** [4:05] 5. **Opportunities in the Peptide Market** [5:41] ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be a part of the Pharmacy Podcast Network**

En Capital Intereconomía, en Empresas con Identidad, hablamos con Marc Pagès, director general de Skello en España, una de las compañías tecnológicas europeas con mayor crecimiento en soluciones para la planificación y gestión de equipos operativos, que acaba de cerrar una ronda de financiación de 200 millones de euros. Durante la entrevista conocemos el modelo de negocio de Skello, cómo ayuda a las empresas a optimizar la gestión de sus plantillas y qué supone esta importante operación de financiación para acelerar su crecimiento y expansión internacional. También analizamos los retos del mercado laboral, la digitalización de los procesos de recursos humanos y el papel de la inteligencia artificial en la organización del trabajo. En Digital Business hablamos con Salvador Mas, CEO de GPTadvisor, para analizar la actualidad del sector tecnológico, marcada por la celebración de un gran evento de innovación y por la petición del Banco Central Europeo a las entidades financieras para que presenten un plan de acción frente a la amenaza que representa el proyecto Mythos. También contamos con Javier Pastor, Head of OTC de Bit2Me, para analizar la actualidad del mercado de los activos digitales. Ponemos el foco en la denominada Crypto Week y en la tramitación de la Ley CLARITY en Estados Unidos, una regulación llamada a definir el marco jurídico de los criptoactivos y que podría marcar un antes y un después para el desarrollo del sector. Y terminamos con Borja Martín de la Torre, cofundador y COO de Meritoo (Remove Group), con quien abordamos la gestión de las crisis reputacionales en las empresas. Analizamos los errores más habituales cuando estalla una crisis, el papel del liderazgo, la importancia de reaccionar a tiempo y cómo una gestión transparente y responsable puede ayudar a recuperar la confianza y reforzar la reputación de una organización.

Anhören, lachen, abstimmen! Von 1LIVE.

When sunny summer days come around, it makes some dermatologists shudder. They would prefer we behave like bats and hide in caves until nightfall. Failing that, they stress the importance of always applying (and re-applying) high SPF sunscreen, wearing sun-blocking clothing with long sleeves and keeping a big-brimmed hat firmly on the head. A beekeeper's outfit might be perfect. But must you really shun the sun completely to save your skin? Our guest describes how to practice moderation safely. He also explains why some people are addicted to sunshine, while others are allergic to it. At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, July 11, 2026, through your computer or smart phone (wunc.org). Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on July 13, 2026. Can You Really Be Addicted to Sunlight? Dermatologists do their best to discourage people from using tanning beds. They describe the damage that ultraviolet light can cause, ranging from wrinkles to skin cancer. For some people, though, those arguments just don't make a difference. Our guest, Dr. Steve Feldman, conducted a study several years ago. The volunteers were accustomed to using tanning beds. In the study, there were two beds, one with the usual ultraviolet light and the other, identical in appearance and temperature, had its UV blocked. After a session in each bed, volunteers were allowed to choose their bed for the last session. They almost invariably chose the bed with the active UV. To follow up, the researchers administered naltrexone, the opioid-blocking medication. When volunteers had taken it, they were no longer able to distinguish which bed was active. It seems that, for these people, ultraviolet light activates pro-opiomelanocortin, which in turn triggers the production of natural opioids called endorphins. Further research imaging the brain during tanning sessions confirmed that the UV exposure was activating areas of the brain associated with pleasure (Psychiatry Research. Neuroimaging, May 30, 2016).  Dr. Feldman and a colleague found that excessive indoor tanning is similar in pattern to substance use disorders (Journal of Cutaneous Medicine and Surgery, May-June 2025). Can You Save Your Skin and Still Enjoy the Outdoors? Dr. Feldman offers advice on avoiding sunburn that is tempered with this fact from epidemiology: people who go out in the sun live longer (International Journal of Environmental Research and Public Health, July 13, 2020).  The goal here is not to shun the sun completely, but rather to exercise enough caution and good judgment to avoid burning your skin. (Who wants to burn, anyway? It hurts, and it looks bad.) Timing your sun exposure carefully is crucial to save your skin from sunburn. You may also be interested in the new sunscreen ingredient the FDA just approved, bemotrizinol. What Can You Do About Heat Rash? When the weather gets hot and bodies get sweaty, heat rash becomes a common complaint. Sweaty skin may develop bumps that can sometimes be very itchy. What do you do to ease the discomfort? If you can cool the skin off, it might help a lot. Of course, people may also suffer from other types of rash. Babies get diaper rash. Women sometimes experience under-breast rash, just as men may develop jock itch. Zinc oxide ointment can often be helpful for these types of rash. Managing Psoriasis Psoriasis is one of Dr. Feldman's special research interests. The red scaly plaques of this skin condition have raised borders. They look a lot like a fungal infection, but there is no fungus present on the skin to cause them. Something else seems to trigger the skin's immune system to react along the same pathways as if there were a fungus. Most of the time, psoriasis is mild enough to manage without costly medications. It actually responds very well to ultraviolet light exposure. UV downregulates the immune system's over-response. While many dermatologists offer UV exposure within their office walls, in the summertime patients could get exposure to sunlight outdoors. This is practical if they avoid the middle of the day, when they might get burned. Another option? Tanning beds also offer an easy way to calibrate the appropriate amount of UV exposure to save your skin from psoriasis. (Most dermatologists don't approve of this one, so don't tell.) One other practical but unorthodox tip for dealing with mild psoriasis. OTC cortisone may not be strong enough to help heal up a red spot. But you could buy Flonase nasal spray or a generic version, fluticasone, over the counter. Spray it on your skin and appreciate the relief. In fact, this could work for a mild case of poison ivy or other skin irritation as well. Severe cases still need a dermatologist's care. What to Do About Atopic Dermatitis Atopic dermatitis is the medical term for eczema. People with allergies or asthma also appear to be more vulnerable to eczema. Dysregulation of the immune mediators interleukin 4 (IL4) or IL13 may be responsible. This condition may appear in a mild form, which can be readily managed, or a more severe form that might require prescription medication. A topical corticosteroid such as triamcinolone will often clear it up. Or you could try spraying on some Flonase nasal spray for a cost-effective low-key approach. Those will actually help the majority of people with mild eczema. Using mild soap rather than detergent-based body wash, moisturizing well and following an anti-inflammatory diet are the pillars of home management. People with more severe atopic dermatitis covering a large portion of the body may need powerful prescription medication rather than topical steroids. Trying to cover so much skin with steroid would probably result in side effects from the cream. Dupixent (dupilumab) is a relatively new self-injectable medication that blocks IL4 and IL13. It works well for most people with atopic dermatitis and has a good safety profile. Certain other drugs in this category, such as Skyrizi (risankizumab), are also pretty safe but very pricey. Stelara (ustekinumab), has been around longer. Biosimilars for Stelara have been approved and are more affordable. Ustekinumab blocks IL12 and IL23. TV ads tout other medicines for this condition as well. Rinvoq (upadacitinib) is three or four times more effective than Dupixent, but it is also super expensive. It is a Janus-kinase (JAK) inhibitor. Xeljanz (tofacitinib) is another potent prescription JAK inhibitor, but it carries an elevated risk of heart attack. Beware of Bug Bites Another summer skin hazard is bug bites. Here unquestionably the best approach to save your skin is avoidance. Appropriate clothing is key. (That beekeeper's suit will come in handy here again.) Dr. Feldman recommends spraying DEET on your pants legs, socks and sleeves rather than directly on your skin. If there are grasses or brush where you have walked, run or played, a tick check immediately upon coming inside is critical. Can AI Help Patients with Skin Problems? It doesn't make sense to tell people to stay off the internet. Some searches can be quite helpful and guide patients in asking their dermatologist the right questions. Dr. Feldman is enthusiastic about DermNet, a New Zealand dermatology website. https://dermnetnz.org  Joe and Terry recommend SkinSight. This Week’s Guest Steven R. Feldman, MD, PhD, is Professor of Dermatology, Pathology, and Social Sciences & Health Policy, at the Wake Forest University School of Medicine.  His research has been published in over 1,000 peer reviewed, Medline-referenced articles. Expertscape.com ranks Feldman among the top experts in the world on psoriasis, acne, dermatology, and treatment adherence. Steve Feldman, MD, in Dermatology clinic, Country Club Commons Listen to the Podcast The podcast of this program will be available Monday, July 13, 2026, after broadcast on July 11. You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

Amid elevated volatility and rapid advances in technology, systematic trading is gaining steam in commodities markets. Join Leland Price from the FICC Market Structure & Liquidity Strategy team alongside commodity traders Max Lee and Biko Agozino as they discuss what's driving the growth of quantitative strategies across commodities and what it means for market participants today. Explore how automation is unlocking access to OTC liquidity, alpha opportunities emerging from inefficiency as well as how API connectivity and AI are shaping the modern trader's toolkit.   This episode was recorded on June 25, 2025.   The views expressed in this podcast may not necessarily reflect the views of JPMorgan Chase & Co, and its affiliates, together J.P. Morgan, and do not constitute research or recommendation advice or an offer or a solicitation to buy or sell any security or financial instrument. They are not issued by Research but are a solicitation under CFTC Rule 1.71. Referenced products and services in this podcast may not be suitable for you, and may not be available in all jurisdictions. J.P. Morgan may make markets and trade as principal in securities and other asset classes and financial products that may have been discussed. The FICC market structure publications, or to one, newsletters, mentioned in this podcast are available for J.P. Morgan clients. Please contact your J.P. Morgan sales representative should you wish to receive them. For additional disclaimers and regulatory disclosures, please visit www.jpmorgan.com/disclosures Copyright 2026 JPMorgan Chase & Co. All rights reserved.

As over-the-counter continuous glucose monitors (CGMs) become more common, clinician guidance matters more than ever. In this episode of BackTable Women's Health, Dr. Nicole Faulkner welcomes Dr. Nicholas Canelo, a family medicine physician and founder of the Perlman Wellness CGM program, to discuss how to effectively guide CGM use in OBGYN practice, from preconception and PCOS to pregnancy and perimenopause. They highlight the importance of interpreting data trends, setting realistic glucose targets, and supporting patients through the practical and emotional challenges of CGM use. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:58 - CGMs in Women's Health07:33 - OTC Data Sharing Issues09:52 - Pregnancy Glucose Targets16:20 - Accuracy and Variability20:10 - Anxiety and Eating Disorders24:41 - Counseling and Follow-Up28:29 - Prescription and OTC CGM Picks37:24 - False Lows and Sensor Errors41:23 - Alarm Settings and Logging44:06 - Interpreting Metrics and Limits46:44 - Provider Dashboards 48:42 - Final Thoughts --- More about this episode Given the lack of well-established blood glucose targets outside of type 1 diabetes, Dr. Canelo reviews commonly used ranges for individuals without diabetes, those with prediabetes, and pregnant patients with type 1 or 2 diabetes. He explains how to interpret CGM data, including the time in tight range, coefficient of variation, and the importance of focusing on overall trends rather than isolated glucose spikes. They also discuss the potential drawbacks associated with CGM use, including anxiety and eating-disorder risks. Practical considerations include sensor inaccuracies, false lows readings, and optimizing alarm settings. Dr. Canelo emphasizes the importance of having patients log meals and other events while wearing the sensor and scheduling follow-up after the initial 15-day wear period to ensure accurate interpretation and effective counseling. Finally, they compare OTC and prescription CGM options, including costs, clinician access to patient data, and insertion tips. --- Resources Stelo - Over the Counter CGM Optionhttps://www.stelo.com/en-us --- BackTable Women's Health is the go-to podcast for gynecologists, gynecologic surgeons, and other healthcare professionals focused on women's health. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Hosts: Ed Jones (Owner – Nutrition World) & Clint Powell A variety of topics all about a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com High baseline of general anxiety in pets; fireworks can escalate it dramatically Rough estimates from Dr. Smith: ~30% with noticeable anxiety ~10% with severe reactions: Destruction of property Defecating/urinating in house Extreme escape behaviors (e.g., dog through plate glass window)  Natural vs Pharmaceutical Support & Timing Severe cases: Trazodone often used; Dr. Smith avoids drugs that completely knock pets out Mentions older drugs (e.g., acepromazine) that overly sedate animals She prefers starting treatment the day before fireworks: Anxiety and pain wind up; if you get behind, it's hard to control Natural options she likes: Melatonin, tryptophan, theanine, GABA Pet products that combine several of these Start 1–2 days before fireworks because neighbors often start early [0:18:58]  Melatonin Dosing & CBD for Pets + Environmental Concerns Melatonin for dogs: Start around 3 mg, can go up, even up to ~10 mg in some cases Must be given at bedtime to preserve serotonin/melatonin rhythm Human reference: some serious disease protocols use up to 50 mg CBD: She likes CBD: generally very safe, large margin before toxicity Important: oil directly in mouth, not hidden in food (stomach acid breaks it down) Treats are OK, but observe individual response Ed notes TN hemp rule change (July 1) hurting many businesses; pet CBD appears less restricted for now Environmental side of fireworks: Harm to birds and nocturnal wildlife Startled flocks flying at night, running into obstacles [0:21:57] About CHAI: Services & Ozone Therapy Chai = Chattanooga Holistic Animal Institute On Main Street, Southside Open ~13–14 years Services: Conventional: surgery, X-rays Integrative: herbal medicine, nutrition-first approach, acupuncture, chiropractic Heavy focus on nutrition as foundation Ozone therapy: Used for cancer (mixing with blood + UVB), ear infections (ear cups), GI issues (ozone enema + fecal transplant) Antiviral, antifungal, antibacterial; research supports it but not mainstream due to lack of patentability Ed shares parallel human ozone experiences and enthusiasm [0:24:27] Regulatory Limits on CBD Advice & Practical Dosing Forms California example: Vets cannot legally discuss CBD with clients, while retail hemp shops can freely advise For cats: Liquids in vegetable glycerin are best Alcohol-based tinctures: cats won't like them (foaming, spitting) Liquids can go in food or directly in mouth For dogs: Easier to hide products, but Dr. Smith dislikes many chews: Often have rice flour, tapioca starch, molasses, smoke flavor (potential carcinogen) Prefers powders and liquids [0:26:16] Why Kibble Is Harmful & Heat Safety for Pets Core problems with kibble: Ultraprocessing damages proteins and fats Produces advanced glycation end products (AGEs)—carcinogenic High carbohydrate; not species-appropriate for carnivorous animals Expensive kibble = “expensive Skittles” – processing is still the issue Better options: Raw, dehydrated, freeze-dried Balanced homemade diets Light cooking under ~200°F for seniors to aid digestibility without denaturing nutrients Heat and Summer Safety for Pets Hot ground + hot air → limit daytime walks, adjust exercise Brachycephalic (“smushy-faced”) dogs at special risk: Pugs, Boston Terriers, bulldogs, etc. Shortened face doesn't reduce internal soft tissue; narrow airways = breathing through a straw Heat + humidity = much higher risk of heat exhaustion; many just lie on A/C vents Cats handle heat better (tend to stay inside), but should still be kept cool and supervised Pool safety: pets often don't know how to get out, so human supervision is essential [0:30:41] Independent Practice vs Corporate Vet Medicine CHAI is one of the last independent practices in town Independence allows: Thinking outside the box and the standard “cookbook” Corporate practices: Strict protocols, less flexibility Vets can't always practice as they'd like [0:36:09] Chemical Aging, Peakspan, and Electrolytes Ed quotes Dr. Keith Scott-Mumby (81-year-old MD) on “chemical aging”: Modern environment “poisons” us: Plastics, can linings, pesticides (glyphosate), microplastics Addictive refined carbs, seed oils Many of these mimic hormones and drive accelerated aging “Chemical aging” shows up as: Hair thinning, dry/crepey skin, age spots Persistent belly fat, “man boobs,” fragile bones, poorly fitting clothes Ed's own book: “Are You Sick and Tired of Being Sick and Tired?” He believes it lays out an A–Z game plan for aging better / “peakspan” Available as an ebook on TheHolisticNavigator.com Electrolytes vs Gatorade; Critique of Mainstream Sports Drinks Context: intense summer heat and need for electrolytes Our bodies run on electrical currents (heart, brain, nervous system) regulated by electrolytes Daily potassium need ≈ 3,400 mg Comparison: 20 oz Gatorade: ~75 mg potassium (very low) 0 mg magnesium ~270 mg sodium ~34–36 g carbohydrates/sugar Gatorade Zero: no sugar but uses sucralose, which Ed says can disrupt the gut microbiome Ed's personal take: Would rather “spend” that sugar on a cheesecake dessert than on Gatorade Example True Grace electrolyte formula (carried at Nutrition World): ~750 mg sodium ~250 mg potassium ~100 mg magnesium ~100 mg cordyceps (supportive for lungs/endurance) Great Naturally has ~700 mg potassium per serving Conclusion: many store-brand sports drinks are nutritionally weak and sugar-heavy compared to targeted electrolyte blends [0:44:27] Pepcid (Famotidine), Serotonin, and Essential Oils for Sore Throat Ed introduces Pepcid (famotidine): H2 blocker commonly used OTC for heartburn Prefers it over long-term proton pump inhibitors (e.g., Nexium) Key claim from research Ed cites: Famotidine uniquely blocks certain serotonin activity Can sometimes help with: Chronic pain Inflammation Fatigue Case example: life-threatening serotonin syndrome reversed in 15 minutes with famotidine Elevated serotonin may: Impair mitochondrial energy production Promote chronic inflammation and, paradoxically, some depression and pain Ed has bought a box himself; recommends it as the safer short-term choice for bad heartburn Essential Oils vs Antibiotics for Sore Throats Study on sore throat treatment: 97 adults with clinically diagnosed sore throat Group 1: penicillin twice daily Group 2: oral essential oils capsule 3× daily Group 3: both Outcomes: 100% improvement in antibiotic group 88% improvement in essential oil–only group 100% improvement in combined group Essential oil blend ingredients: Oregano, eucalyptus, lemon, cinnamon, pine oils Clint raises important question: absent a no-treatment control, some percentage may have improved naturally) Quick guide to buying quality beef: Prefer “100% grass-fed” over just “grass-fed” Look for or confirm grass-finished (often not on labels due to cost; best to know your farmer) Beware empty buzzwords: “natural,” “farm raised,” “pasture inspired” Real grass-fed/finished usually costs more due to land/time inputs Fat color: Slight yellow hue suggests carotenoids from real forage [0:53:35] Strength, Independence, and Vitamin D Ed references recent high-production video interview in Atlanta Draws inspiration from Jack LaLanne: Early television fitness and vitamin pioneer Nutrition World once helped bring him to Chattanooga; he lived to ~95 Paraphrased LaLanne theme: Strength gives you options: Carry your own groceries Climb stairs confidently Travel, explore, stay active Play with grandchildren, work in the yard, maintain independence Without strength: Tasks become difficult Confidence drops Independence shrinks; world gets smalle Ed reiterates: muscle is the organ of longevity and needs: Regular weight training Adequate protein Targeted supplementation Discussion of vitamin D: Ed's recent lab: ~54 ng/mL despite summer tan Wants to remain above 50 ng/mL year-round; may increase winter dosing Clint mentions his last check (~3 years ago) was ~70 ng/mL, even before supplementation  The post Radio Show / Podcast – July 5, 2026 first appeared on Vital Health Radio.

Mark Longo sits down with two key executives from Options & Company—Jorge Lobo, Head of Treasury, and Ivyson Vilanova, CFO—for a fascinating look inside Brazil's evolving options marketplace. Options & Company has built its business around improving liquidity, transparency, education, and access for Brazilian options traders. In this conversation, Jorge and Ivyson explain how the firm is helping address some of the biggest challenges facing Brazil's derivatives market while also pursuing ambitious plans for international expansion. The discussion explores the current state of the Brazilian options ecosystem, the dominance of OTC structured products, the need for greater retail investor education, and how Options & Company is working to bring tighter spreads and more efficient markets to investors across Brazil. Mark and his guests also discuss: • The mission and growth of Options & Company • Why options education remains a major opportunity in Brazil • Liquidity challenges in Brazilian listed options • The role of OTC products in the retail marketplace • Brazil's most active sectors and underlying names, including Petrobras, Vale, Itaú, and Nubank • Why international investors are taking a fresh look at Brazil • Plans for Options & Company's expansion into the United States and other global markets • The potential impact of a second Brazilian derivatives exchange • How the Brazilian options market differs from the U.S. market • Why trends like 0DTE and 24-hour trading remain years away from widespread adoption in Brazil

Mark Longo sits down with two key executives from Options & Company—Jorge Lobo, Head of Treasury, and Ivyson Vilanova, CFO—for a fascinating look inside Brazil's evolving options marketplace. Options & Company has built its business around improving liquidity, transparency, education, and access for Brazilian options traders. In this conversation, Jorge and Ivyson explain how the firm is helping address some of the biggest challenges facing Brazil's derivatives market while also pursuing ambitious plans for international expansion. The discussion explores the current state of the Brazilian options ecosystem, the dominance of OTC structured products, the need for greater retail investor education, and how Options & Company is working to bring tighter spreads and more efficient markets to investors across Brazil. Mark and his guests also discuss: • The mission and growth of Options & Company • Why options education remains a major opportunity in Brazil • Liquidity challenges in Brazilian listed options • The role of OTC products in the retail marketplace • Brazil's most active sectors and underlying names, including Petrobras, Vale, Itaú, and Nubank • Why international investors are taking a fresh look at Brazil • Plans for Options & Company's expansion into the United States and other global markets • The potential impact of a second Brazilian derivatives exchange • How the Brazilian options market differs from the U.S. market • Why trends like 0DTE and 24-hour trading remain years away from widespread adoption in Brazil

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 or https://www.barnesandnoble.com/w/book/1144514092?ean=9781570674242 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. Get the book here:https://www.amazon.com/shop/chefaj/list/1GNPDCAG4A86S?ref_=aip_sf_list_spv_ofs_mixed_d&ccs_id=ed4dfdad-3f74-40fb-b5ab-b34f9821b312 John Abramson MD, MSc After completing a residency in Family Medicine and a 2-year Robert Wood Johnson fellowship, Dr. John Abramson practiced as a family physician for 20 years in a small town an hour north of Boston. He also served for 7 years as chair of the department of family practice at Lahey Clinic. He was on the Harvard Medical School faculty from 1997-2023, most recently as a Lecturer in the Department of Health Care Policy. In 2002, after becoming aware of the uncorrected misrepresentations about the benefits and dangers of Vioxx and Celebrex in our most respected medical journals, Dr. Abramson left his practice to devote his full attention to researching the quality of the information doctors must rely on. In September 2004 he published Overdo$ed America: The Broken Promise of American Medicine. Just one week later, Vioxx was withdrawn in the biggest drug recall ever, but not before it had killed between 40 and 60,000 Americans, despite providing no better relief than inexpensive OTC anti-inflammatory drugs. From 2005 through the present, Dr. Abramson has continued his research and served as an expert in litigation involving prescription drugs and medical devices, with each case giving him access to millions of pages of confidential corporate documents and unreleased clinical trial data. He has also served as a consultant to the FBI and U. S. Department of Justice, including a case that led to what was, at the time, the largest criminal fine in U.S. history. Dr. Abramson has published multiple articles in peer reviewed journals, made numerous national media appearances, and written many op-ed pieces, including 2 in the New York Times. His main research interest is the extent to which the commercial takeover of medical knowledge, primarily by the drug companies, is compromising the quality of medical information available to even the most dedicated doctors, harming our health, and wasting enormous amounts of Americans' wealth. In February 2022 Dr. Abramson published his second book, Sickening: How Big Pharma Broke American Health Care and How We Can Repair It.

Ever stood frozen in the pharmacy aisle, holding two bottles with no idea which one actually works? You're not alone — and Shanley Chien is here to help. As Senior Health Editor at U.S. News & World Report, Shanley led a survey of nearly 500 pharmacists and dermatologists across 128 categories to find the best over-the-counter products out there — with not a single brand paying to be on the list. In this episode, Wendy and Shanley cut through the “paralysis by analysis” and build your Healthy-Aging Shelf: the pro-approved picks for skin and hair, hormones and menopause, sleep, strength, and gut health in midlife. From CeraVe and La Roche-Posay to Estroven, Vital Proteins, Voltaren, and Metamucil, you'll walk away knowing exactly what to reach for. No hype, no guesswork. Just what works.

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

Most people see a global company and assume success happened overnight.What they don't see are the years of persistence, the skepticism, and the countless decisions required to turn a vision into reality.In this episode of Startup to Stock Exchange, Seth Farbman sits down with Leandro Iglesias, CEO of IQSTEL, and Alvaro Quintana, CFO of IQSTEL, to discuss how they transformed a telecom startup into a publicly traded global business operating across 30 countries.The conversation explores IQSTEL's journey from a $10 million revenue company to a business approaching a $500 million run rate, their path from the OTC markets to Nasdaq, and how they're evolving beyond telecom into AI, cybersecurity, fintech, and digital health services.Leandro and Alvaro also share their acquisition strategy, lessons from managing teams across multiple continents, and why they believe the company's biggest growth opportunities are still ahead.Whether you're a founder, investor, or business leader, this episode offers valuable insights into scaling internationally, leveraging public markets, and building a company with long-term vision.Guests featured in the episode:Leandro Jose Iglesias, CEO at IQSTEL : https://www.linkedin.com/in/leandro-jose-iglesias-20940818/Alvaro Quintana Cardona, CFO at IQSTEL: https://www.linkedin.com/in/alvaro-quintana-cardona-921494/IQSTEL: https://www.iqstel.com/Seth's CompaniesVstock Transfer – https://www.vstocktransfer.com/Share Media – https://www.sharemedia.co/Listen to the ShowApple Podcasts – https://podcasts.apple.com/us/podcast/seth-farbman-on-podcast-from-startup-to-stock-exchange/id1356667808Spotify – https://open.spotify.com/show/54i7xkWaAALAFrUvk4WZcNConnect with SethLinkedIn – https://www.linkedin.com/in/sethfarbman/Instagram – https://www.instagram.com/sethfarbmanstockTikTok – https://www.tiktok.com/@sethfarbmanTwitter (X) – https://x.com/sethfarbman1About the ShowFrom Startup to Stock Exchange, hosted by entrepreneur and investor Seth Farbman, spotlights the journey of founders and CEOs as they scale their companies from early ideas to public markets. Each episode features candid conversations with leaders across industries, offering insights on growth, fundraising, branding, and the mindset it takes to build a company that lasts.Chapters:00:00 Intro & Meet the IQSTEL Leadership Team01:55 How IQSTEL Started 18 Years Ago04:00 The Reality of Becoming a Public Company05:45 From Telecom Company to AI, Cybersecurity & Fintech09:00 Growing Revenue from $13M to $400M+11:40 How the CEO and CFO Built the Company Together14:40 Managing a Business Across 30 Countries18:00 The Acquisition That Could Push IQSTEL Past $500M24:15 Why Banks Said Their Vision Was Impossible28:15 Why IQSTEL Chose the Public Markets30:45 The Road to $1 Billion Revenue33:00 What's Next for IQSTEL and Its ShareholdersConnect with Seth LinkedIn – https://www.linkedin.com/in/sethfarbman/ Instagram – https://www.instagram.com/sethfarbmanstock TikTok – https://www.tiktok.com/@sethfarbman Twitter (X) – https://x.com/sethfarbman1

On this episode of The Still Real to Us Show:-- Sami Zayn Holds the Fate of the Undisputed WWE Championship in His Hands! Sami has been named the special guest referee for Cody Rhodes vs. Gunther on SmackDown, but can he remain impartial—or is controversy inevitable?-- "Come and Get Me!" Solo Sikoa Rejects Roman Reigns as Jacob Fatu Chooses a Side! Jacob Fatu delivers a direct message from Roman Reigns, Solo fires back with a challenge to the OTC, and Fatu officially joins The Bloodline. Is the next chapter of The Bloodline Civil War about to begin?-- Who Will Wear the Crown? King & Queen of the Ring and Owen Hart Tournament Predictions! Oba Femi's monster run continues, IYO SKY moves one step closer to the throne, Mercedes Moné punches her ticket to the Owen Hart Finals, and Will Ospreay vs. Swerve Strickland feels bigger than ever. We break down every tournament and predict who leaves with the crown and who leaves with the cup!-- Has TNA's Comeback Already Run Out of Steam? After a much-talked-about resurgence, TNA is dealing with talent departures, declining attendance, production cuts, and questions surrounding the WWE partnership. Is this just a rough patch—or are the warning signs impossible to ignore?

 In this special live episode recorded at the Country Music Hall of Fame in Nashville, Tennessee during the Sustainable Packaging Coalition Impact Event, Cory Connors shares the stage with Olga Kachook to present the Third Annual Sustainable Packaging Trends Report for 2025–2026. Olga walks through the four key trends shaping the industry and dives deeper into each one in conversation with Cory, covering everything from EPR maturity to innovation in healthcare packaging.Key Topics Discussed:Regions defining recyclability — Canada, the UK, and the EU leading the way and what that means for the USInnovation breakthroughs in OTC and healthcare packaging, including paper prescription bottlesEPR turning five — progress made and challenges that remainShared data driving recyclability clarity, including the upgrade of polypropylene cold cups under the How to Recycle programDesigning for EPR — setting your own certainty in the face of regulatory uncertaintyThe "magic wand" thought experiment: how would you design your packaging portfolio if starting fresh today?Coated paper and molded fiber as focus areas for the SPC's paper recyclability collaborativeThe role of AI sorting technology in generating better recycling dataReusable e-commerce as an emerging opportunity — FedEx and Returnity's B2B partnershipPredictions for the 2027 Trends Report, including consumer education and infrastructure expansion in EPR statesCabinet Health's refillable OTC packaging model, available at Target and AmazonResources Mentioned:Sustainable Packaging Coalition (SPC) SPC Paper Recyclability CollaborativeHow to Recycle ProgramCabinet Health — refillable OTC packagingNextGen ConsortiumReturnity Reusable ShippingContact: For more information on the SPC Trends Report, scan the QR code mentioned in the episode or visit sustainablepackaging.org.Thank you for tuning in to Sustainable Packaging with Cory Connors, presented by Atlantic Packaging!Support our Sponsors Learn more here:- 3M- Specright- Forest Connect with CoryConnect with Cory on LinkedIn here: https://www.linkedin.com/in/cory-connors/I'm here to help you make your packaging more sustainable! Reach out today and I'll get back to you asap. This podcast is an independent production and the podcast production is an original work of the author. All rights of ownership and reproduction are retained—copyright 2022.

Is El Salvador truly a Bitcoin paradise, or are banks winning the war? AsoBitcoin President Will Hernandez (@whbitcoin) reveals the truth about banking, taxes, and real estate.If El Salvador is the ultimate haven for financial freedom, why is it still an absolute nightmare for a Bitcoin company to open a simple savings account? There is a massive disconnect between political idealism and reality on the ground even though several years have passed since the historic bitcoin law entered into force. In this episode, Will Hernandez, President of the El Salvador Bitcoin Association (AsoBitcoin), joins us in the studio to pull back the curtain on what it actually takes to operate a business inside the first country to make Bitcoin an official legal tender.We tackle the legacy financial system because it represents the biggest battleground for business owners right now. Traditional Salvadoran banks are actively utilizing their legal right of refusal to lock out crypto startups, which proves that institutional hostility remains a major hurdle. To bypass this friction, we lay out a major three month challenge for the association to develop a sovereign tax framework alongside the government. If businesses can pay their corporate and payroll taxes entirely in Bitcoin via OTC intermediaries, entrepreneurs can finally opt out of the fiat system and achieve true corporate asset protection.International capital continues to flood into the country due to unprecedented corporate tax incentives. Will explains how international founders are completely restructuring their corporate balance sheets because El Salvador charges zero percent capital gains tax when you hold a digital asset in your corporate treasury. This unique tax exemption has triggered a massive boom in the local property market, and it has transformed the coastline into a global hotspot for real estate investment where buyers use specialized OTC desks to close deals entirely on a bitcoin standard.The grassroots movement is winning the long game through localized Bitcoin circular economies while legacy institutions stall. From surf towns like El Zonte to new tech hubs, communities are building a parallel economy where everyday users constantly refine the software UX. Will emphasizes that the next critical step involves structural education, and he is pushing the Ministry of Education to mandate Bitcoin literacy in private school curriculums so that the next generation natively understands sound money systems.El Salvador is already positioning itself for the next technological super-cycle by exploring the intersection of decentralized money and sovereign AI. The government is actively pushing its own officials to adopt these emerging technologies because it anticipates a future where autonomous AI agents use the Bitcoin network for automated machine-to-machine payments. This episode provides an unfiltered, boots-on-the-ground look at the triumphs, structural bottlenecks, and future of the ultimate macroeconomic experiment.If you enjoyed this episode and want to keep supporting open source freedom money, please make sure to subscribe to the channel, share this with a fellow Bitcoiner, and drop a comment below. Just let us know if you think Will can pull off the tax challenge in three months or if Mike needs to call him out on the next show.—Bitcoin Beach TeamLearn more about Will Hernandez:X: https://x.com/whbitcoinIG: https://www.instagram.com/whbitcoin/LinkedIn: https://www.linkedin.com/in/whbitcoin/Web: https://www.asobitcoin.org/Support and follow Bitcoin Beach:X: https://www.twitter.com/BitcoinBeach IG: https://www.instagram.com/bitcoinbeach_sv TikTok: https://www.tiktok.com/@livefrombitcoinbeach Web: https://www.bitcoinbeach.com Browse through this quick guide to learn more about the episode:00:00  Intro01:48  Will Hernandez: The famous 3 BTC birthday piñata story03:37  Why Bitcoin entrepreneurs must study the Satoshi white paper06:36  How AsoBitcoin filters out crypto scams in El Salvador09:31  Is the El Salvador Bitcoin Association private or government?13:28  Why do traditional banks in El Salvador reject Bitcoin startups?15:05  What is the El Salvador Law of Alternative Funds?17:26  How to buy real estate in El Salvador using Bitcoin and OTC desks24:34  How to pay corporate taxes on a pure Bitcoin standard28:58  Pushing for a mandatory Bitcoin curriculum in private schools36:09  Sovereign AI: How autonomous agents use Bitcoin for paymentsLive From Bitcoin Beach

Semaglutide Slows Biological Aging A randomized, placebo-controlled study published in Nature Communications found semaglutide slowed biological aging markers by nine percent on the DunedinPACE epigenetic clock in adults living with HIV-associated metabolic disease, with simultaneous improvements across inflammation, heart, kidney, liver, and brain markers. Host Dave Asprey breaks down why this isn't a weight loss story. It's a metabolic inflammation story. He explains why the GLP-1 mechanism hitting insulin signaling, oxidative stress, and inflammatory pathways simultaneously is the real finding, and makes the case that your metabolic markers and your aging markers are the same numbers. Sources: https://www.medicalnewstoday.com/articles/glp-1-drugs-ozempic-wegovy-may-slow-biological-aging https://www.nature.com/articles/s41467-026-72861-3 https://today.ucsd.edu/story/study-popular-glp-1-drug-may-slow-down-biological-aging FDA Approves First New Sunscreen Ingredient in 20 Years The FDA approved bemotrizinol as a permitted OTC sunscreen active ingredient, the first new approval in roughly two decades, clearing it for adults and children six months and older with broad UVA and UVB coverage and low skin absorption. Host Dave Asprey explains why twenty years of regulatory lag left American consumers with inferior chemistry while Europe moved on, why he's watching independent absorption data before updating his own stack, and why consistency of use matters more than perfect formulation when sun protection remains one of the most evidence-backed longevity interventions available. Sources: https://www.fda.gov/news-events/fda-newsroom/press-announcements/fda-expands-sunscreen-options-first-time-20-years https://www.accessdata.fda.gov/scripts/cder/omuf/index.cfm?event=OrderDetail&orderid=OTC000039 https://www.usatoday.com/story/news/health/2026/06/09/new-sunscreen-ingredient-bemotrizinol/90477659007/ Deoxyribose Gel Matches Minoxidil in Hair Regrowth Study Researchers testing a topical gel made from deoxyribose, the sugar backbone of DNA, saw roughly 80 to 90 percent hair regrowth in a mouse model of male-pattern baldness, matching minoxidil results and showing new follicle formation and increased blood vessel activity in treated areas. Host Dave Asprey breaks down why mouse hair regrowth studies have a long history of failing to translate to humans, what a plausible circulation-based mechanism would actually need to show in human trial data before it's worth acting on, and why the molecule itself is interesting enough to keep watching. Sources: https://www.reddit.com/r/Biohackers/comments/1tyt87w/researchers_found_that_a_gel_made_from/ https://www.sciencealert.com/surprise-hair-loss-breakthrough-a-dna-sugar-gel-sparks-robust-regrowth Caffeinated Chewing Gum and Exercise Performance A systematic review and meta-analysis of 21 studies found caffeinated chewing gum produces a small but real ergogenic effect for muscular strength and countermovement jump height, with buccal absorption delivering caffeine faster than capsules or drinks in a five to twenty-five minute pre-training window. Host Dave Asprey breaks down why delivery mechanism is an underrated variable in caffeine optimization, why timing matters as much as dose, and why a modest but measurable edge on a cheap and accessible tool is exactly the kind of practical biohack worth understanding. Sources: https://pubmed.ncbi.nlm.nih.gov/42228847/ https://doi.org/10.1519/JSC.0000000000005530 https://www.reddit.com/r/Biohackers/comments/1u0acgc/fastacting_caffeine_does_caffeinated_chewing_gum/ Vitamin A Overdoses Surge Nearly 40 Percent Medical News Today reported a 38.7 percent spike in vitamin A overdoses in early 2025, driven by online misinformation claiming high-dose vitamin A treats or prevents measles, a claim with no clinical support and real toxicity risk from fat-soluble accumulation in the liver. Host Dave Asprey explains the actual hepatotoxicity and bone demineralization risks of preformed retinol excess, draws the critical distinction between preformed retinol and beta-carotene that got lost in the misinformation cycle, and makes the case that mechanism is not a dosing protocol and confusing the two is how people get hurt. Sources: https://www.medicalnewstoday.com/amp/articles/vitamin-a-overdoses-rose-by-38-7-2025-how-to-get-right-amount World Cup 2026 and Mass Gathering Health Risk With the 2026 FIFA World Cup underway, public health researchers are flagging dense international crowds, high-volume travel, and shared indoor and outdoor spaces as an elevated transmission environment for respiratory illness. Host Dave Asprey reframes the conversation away from germ exposure and toward immune terrain, explains why your resilience going into a high-contact environment is a variable you actually control, and lays out the pre-exposure preparation window that matters most for anyone traveling or attending large events this summer. Sources: https://www.healthline.com/health-news/2026-fifa-world-cup-health-risks-protect-yourself This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on GLP-1 aging biology, sunscreen chemistry and regulatory science, emerging hair regrowth research, caffeine delivery optimization, supplement toxicity risk, and immune terrain preparation for mass gathering events. Host Dave Asprey connects randomized clinical data, epigenetic clock research, consumer health regulation, and real-world optimization protocols into actionable frameworks for extending healthspan, sharpening performance, and staying ahead of the science. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: semaglutide biological aging, GLP-1 epigenetic clock, DunedinPACE aging marker, PCGrimAge mortality risk, bemotrizinol FDA approval, new sunscreen ingredient 2026, UVA UVB broad spectrum sunscreen, deoxyribose hair gel, minoxidil alternative hair regrowth, caffeinated chewing gum performance, buccal caffeine absorption, pre-workout caffeine timing, vitamin A overdose toxicity, preformed retinol hypervitaminosis, fat-soluble vitamin accumulation, World Cup 2026 health risk, immune terrain optimization, mass gathering respiratory illness, biohacking news 2026, longevity research, Dave Asprey, The Human Upgrade Thank you to our sponsors! - Viome | Check it out at viome.com and use code 10DAVE for 10% off. It's time to stop guessing and start knowing your body. - Beyond Wonderland Conference | Oct 13 - 14, 2026. Get your ticket now at wonderlandconference.com. - iRestore | Reverse hair loss at www.irestore.com/DAVE and get exclusive savings on the iRestore Elite, use code DAVE Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Intro 00:41 – Story 1: Ozempic Slows Aging Clocks 01:53 – Story 2: New Sunscreen Approved 03:12 – Story 3: DNA Sugar & Hair Regrowth 04:38 – Story 4: Caffeine Gum & Performance 06:13 – Story 5: Vitamin A Overdose Spike 07:59 – Story 6: World Cup & Immune Prep 09:34 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Didier Deschamps' titans enter this year's World Cup as the team to beat. Champions in 2018 and runners-up in 2022, Les Bleus are the favourites in North America. But can they reclaim this most coveted crown?Andy is joined by OTC regular Jonathan Johnson to dissect France's star-studded squad. Is Kylian Mbappé's influence helpful - or harmful? How do Michael Olise, Ousmane Dembélé and Désiré Doué fit into a stacked front line? What will be sacrificed for glory?Ask us a question on X, Instagram and TikTok, and email us here: otc@footballramble.com.For ad-free shows, head over to our Patreon and subscribe: patreon.com/footballramble.***Please take the time to rate and review us on Apple Podcasts or wherever you get your pods. It means a great deal to the show and will make it easier for other potential listeners to find us. Thanks!*** On The Continent is your definitive podcast for European football. Subscribe for new podcasts every single week and throughout the 2026 FIFA World Cup. Hosted on Acast. See acast.com/privacy for more information.

Jeff and Zack have the opportunity to sit down and chat with Washington State Department of Fish and Wildlife Ungulate Section Manager Kyle Garrison and Ungulate Specialist William Moore to get a debrief on all things Washington Ungulates, herd numbers, and chat about the OTC vs Draw Only system changes that could be proposed in the next few years. We are very thankful to them for stepping out on a branch to do this podcast and hope it is just the first of many to come so we can begin to have more transparency between the department and the hunting public of this state.  LINKS: KUIU GEAR - https://kuiu.sjv.io/GK1o7m EXO MOUNTAIN GEAR - https://exomtngear.com?ref=4 VORTEX OPTICS - https://alnk.to/cSJYlok MARSUPIAL GEAR - https://alnk.to/5FcU7YA ZOLEO - https://tinyurl.com/428ydbua PNWILD - https://www.pnwild.com/store-snytH DEVOS OUTDOOR LIGHTING - https://rstr.co/devosoutdoor/15643 COUPON CODES: OLLIN DIGISCOPE - PNWILD CANYON COOLERS - PNWILD10 VORTEX CLOTHING - PNW20 ZOLEO SATELLITE - PNWILD (Free Activation) VELOTRIC E-BIKES - PNWildN2X01 PNWILD - YOUTUBE If you want to learn more about PNWild visit https://pnwild.com/ INSTAGRAM: @pnwild_ https://www.instagram.com/pnwild_/?hl=en FACEBOOK: / pnwild TIKTOK: @pnwild_ / pnwild_ Got questions? Send us an email! Email: contact@pnwild.com Find all PNWild Partners and Codes here: https://www.pnwild.com/partners

Matt and Nic are back for another week of news and deals. In this episode:  FIFA's World Cup ticketing scandal Andrew Yang is now a crypto and telecoms entrepreneur Are Strategy's woes responsible for the Bitcoin pullback? Will Saylor defend STRC or MSTR? What are Saylor's options here? Polymarket has another market resolution SNAFU How UMA could be used to exploit Polymarket BitMine considers a perpetual preferred security Google's quantum circuit is optimized by hobbyists Galaxy launches OTC trading for prediction markets Treasury sanctions Iran's largest digital asset exchanges Andrew Left of Citron research is convicted of securities fraud

You may think of allergies as causing sniffly noses and congestion in the spring or fall. But allergies can go far beyond that. As Dr. Kari Nadeau points out in this episode, allergies can affect us from head to toe, including eyes, nose, throat, lungs, sinuses, skin and gut. In the most dangerous instances, the whole body is threatened with an anaphylactic reaction. That's a medical emergency! One in three Americans will develop allergies at some point in our lives, so it's important to know what works to control them. At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, June 6, 2026, through your computer or smart phone (wunc.org).  Here is a link so you can find which stations carry our broadcast. (Welcome, Huntsville, Alabama!) If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on June 8, 2026. What Are Allergies? We begin our discussion of your allergy survival guide with an explanation of what is happening during an allergic reaction. The immune system perceives some foreign compound, usually a protein, as dangerous even though normally it would not be. So it reacts by trying to flush the invader out by producing extra mucus. The turbinate sinuses can make one to two gallons of mucus a day, and naturally, it has to go somewhere. That's why you might be congested. Having all that mucus in the sinuses can also encourage bacterial growth, so if the allergic reaction persists, some people have to deal with sinus infections. Emergency Treatment In determining what works, you need to know the nature of the reaction. If you have two or more organs involved, if you are having trouble breathing or if you feel dizzy, you may be in the midst of an anaphylactic reaction. What works for that is an epinephrine injection and immediate medical attention. This is potentially life-threatening, so you will want to figure out what triggered the reaction so you can avoid it in the future. Once someone has suffered one anaphylactic reaction, they should keep epinephrine with them at all times in case of another episode. Epinephrine comes as a self-injector pen or a nasal spray (neffy). Can You Spot Drug Allergies? In the warnings that are rattled off as part of a TV ad for a pricey new drug, we often hear viewers cautioned not to take the medicine if they are allergic to it. That sounds like simple common sense, but it also has a Catch 22 quality. How do you know you are allergic to a medication unless you take it–and experience an allergic reaction for which you might need treatment. Most of these presumably are immune system-mediated reactions, in which the body produces IgE. That is how allergies to penicillin or sulfa drugs work. Some drugs cause a different type of reaction, not IgE-mediated but dangerous nonetheless. Lisinopril is the most commonly prescribed blood pressure medicine in this country. Like other ACE (ACE is short for angiotensin-converting enzyme) inhibitor medications, lisinopril can trigger angioedema. This swelling can affect the face, lips, tongue and throat, where it can compromise breathing. The most insidious aspect of this reaction is that it can occur after the person has been taking the drug without problems for weeks, months or even years. “Red man syndrome” or infusion reactions in people taking vancomycin can likewise occur without warning. The last type of drug reaction is not actually an allergy at all, although people occasionally use that terminology. It is better described as sensitivity. For example, a stomachache is a common reaction to the antibiotic erythromycin. Some people are disabled by this abdominal pain and try to limit their exposure to erythromycin thereafter. What Works and What Doesn't? Since the immune system is acting inappropriately to cause allergic reactions, treatment should involve immunotherapy. Eye drops can help eyes feel less itchy and irritated. Likewise, OTC nose drops or nasal sprays can often help the nose. The corticosteroid Flonase (fluticasone) and the antihistamine Astepro (azelastine) are good examples. During allergy season, some people find that a daily nasal wash (with a neti pot or NeilMed device) can help reduce the mucus and remove the allergens such as pollen causing the reaction. There are also oral antihistamines and inhalers for asthma. For decades now, allergists have offered their patients shots to help desensitize them to the allergen causing their trouble. Joe had these as a child and teenager and has been largely free of allergies since. Not everyone gets such lasting relief. Complications from Current Therapies Medications have side effects, and that is true of allergy medicines as with other drugs. Antihistamines, especially the older ones like Benadryl (diphenhydramine), are notorious for causing drowsiness. That's one reason it is often included in nighttime pain relievers as the “PM” in drugs like Advil PM. We worry about regular use of such antihistamines because it has been linked to a greater risk for dementia. A second-generation antihistamine such as Allegra (fexofenadine) is much less likely to make someone feel sleepy. However, Dr. Nadeau has seen patients on antihistamines suffer worse allergies if they stop suddenly. The People's Pharmacy has received hundreds of reports from people who experienced unbearable itching upon discontinuing Zyrtec (cetirizine) or Xyzal (levocetirizine). This can last for weeks. Doctors don't usually worry much about steroid nasal sprays like Flonase because they are topical. Presumably, nasal tissues pick up most of the dose. Just the same, using such a nose spray day after day for a long time could result in systemic steroid exposure that is not trivial. Stronger Medicine Dr. Nadeau is enthusiastic about the benefits of two potent prescription medicines. One is Xolair (omalizumab). It was originally developed to prevent asthma, but is now approved for chronic sinusitis, food allergies and chronic hives. Paradoxically, Xolair is one of those medicines that could cause a severe allergic reaction even on the first dose, so the FDA warns that the initial injection should be given in a healthcare setting prepared to treat anaphylaxis. This is uncommon, though, occurring in 0.1 to 0.2% of patients. The other medication Dr. Nadeau is prescribing for allergy patients who don't respond well to other treatments is Dupixent (dupilumab). The FDA has approved this medicine to treat a wide range of conditions, including eczema, asthma, chronic sinusitis, allergic reactions affecting the esophagus and chronic hives, among other things. Most insurance companies will not cover this pricey injection unless the patient has failed all other therapies. Fighting Air Pollution: What Works Air pollution makes allergy symptoms worse, so using an effective air filter inside the home is a good step. A HEPA (high-efficiency particulate-arresting) filter is ideal, especially as part of the air-handling system. If that's not possible, utilizing a MERV 13 in the part of the home where you spend the most time is a good second choice. Sonu One new option for treating allergies is acoustic resonance therapy with the SoundHealth Sonu headband. It uses vibration from sound to loosen mucus from the sinuses so that they can clear. The FDA has approved its use for children as well as adults. New research was just published demonstrating its helpfulness in treating children with nasal congestion (Oto-Open, April-June 2026). SoundHealth has underwritten The People's Pharmacy podcast. Dr. Nadeau has also been compensated for her role in conducting studies of this device (International Forum of Allergy & Rhinology, Dec. 2025). Since it does not employ medications, there are no drug side effects. This Week’s Guest Kari C. Nadeau, M.D., Ph.D., is Dean of the UCLA Fielding School of Public Health ( starting July 1 2026). Until then, she holds many other positions. At Harvard T. H. Chan School of Public Health she is: John Rock Professor of Climate and Population Studies; Chair of the Department of Environmental Health; and Director of the Allergy, Extreme Weather, and Exposomics Lab. Dr. Nadeau is Professor of Medicine at Harvard Medical School and serves in the Division of Allergy and Inflammation at Beth Israel Deaconess Medical Center. She is an Adjunct Professor at Stanford Medical School. Dr. Nadeau is also the co-author of The End of Food Allergy, which provides strategies for treating and preventing food allergies in children. Here is a link to the research underway in her Harvard laboratory. PHOTO CREDIT: STACY GEIKENTaken in April 2017 at Kari Nadeau’s professorship dinner The End of Food Allergy: The Science-Based Plan That Turns Food into Medicine The People's Pharmacy is reader supported. When you buy through links in this post, we may earn a small affiliate commission (at no cost to you). Listen to the Podcast The podcast of this program will be available Monday, June 8, 2026, after broadcast on June 6. You can stream the show from this site and download the podcast for free. This episode has additional information about Nasalcrom (cromolyn sodium nasal spray) and its effect on mast cells; alpha gal allergy to red meat; and the latest thinking on preventing peanut allergy among young children. Download the mp3

0:00 – Ludwig Kaiser before Ludwig Kaiser10:45 – Roman discussion22:30 – Roman discussion33:15 – Roman discussion45:10 – Roman discussion55:50 – Roman discussion1:05:30 – Roman discussion1:16:15 – Roman Reigns and the boring Bloodline discussion1:22:45 – Show endBecome a supporter of this podcast: https://www.spreaker.com/podcast/wrestling-soup--1425249/support.

Most people assume that if a drug sits on the shelf at Costco or Walgreens, it must be pretty safe. But what if some of the most common over-the-counter (OTC) medications are among the riskiest drugs in America? On this vintage episode of Vitality Radio, Jared exposes the hidden dangers behind everyday pain relievers, sleep aids, and heartburn drugs—medicines that cause thousands of deaths every year when misused or taken long-term. You'll learn how a drug becomes “OTC,” what happens when pharmaceutical companies push for that switch, and why the FDA's approval process might not tell the whole story. Jared dives into the startling realities of PPIs like Prilosec, NSAIDs like ibuprofen, and acetaminophen (Tylenol)—uncovering their risks to the liver, kidneys, bones, and brain. He also discusses how marketing convinces consumers these drugs are harmless. Finally, Jared offers a resource for safe, natural alternatives for reflux, pain, inflammation, sleep, and immune support—options that nourish the body instead of depleting it. This episode will change the way you look at “harmless” OTC drugs and help you take real control of your health.Additional Information:#341: Your Digestive Health Supplement User's Guide. From IBS to Acid Reflux - Learn How to Balance Your Gut Health With Natural Products. #522: Q&A Show #5 - Jared Answers Your Questions About Energy and Sleep!#471: Boosting Your Immune System Ahead of Winter #553: Boswellia & Curcumin: Nature's Dream Team for Pain & Inflammation with Dr. Lexi LochVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.